| For: | Martin-Grau M, Marrachelli VG, Monleon D. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn? World J Hepatol 2022; 14(2): 304-318 [PMID: 35317178 DOI: 10.4254/wjh.v14.i2.304] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i2/304.htm |
| Number | Citing Articles |
| 1 |
Lorena Valdés-Varela, Ignacio Goyache, Raquel Virto, Neira Sáinz, Miguel López-Yoldi, Ana Sánchez-Vicente, Noelia López-Giral, Ana Gloria Gil, Fermín I. Milagro, Paula Aranaz.
Companilactobacillus alimentarius CNTA 209 alleviates diet-induced obesity in mice through adipose tissue browning and gut barrier modulation. Food & Function 2026; 17(6) doi: 10.1039/D5FO04242A
|
| 2 |
Sergio Carracedo, Lisa Lirussi, Lene Alsøe, Filip Segers, Changliang Wang, Zdenka Bartosova, Pavol Bohov, Nuriye B. Tekin, Xiang Yi Kong, Q. Ying Esbensen, Liang Chen, Anna Wennerström, Penelope Kroustallaki, Deborah Ceolotto, Anke Tönjes, Rolf Kristian Berge, Per Bruheim, Garry Wong, Yvonne Böttcher, Bente Halvorsen, Hilde Nilsen. SMUG1 regulates fat homeostasis leading to a fatty liver phenotype in mice. DNA Repair 2022; 120 doi: 10.1016/j.dnarep.2022.103410
|
| 3 |
María Martín-Grau, Pilar Casanova, Laura Moreno-Morcillo, José Manuel Morales, Vannina G. Marrachelli, Daniel Monleón. Microbiota Co-Metabolism Alterations Precede Changes in the Host Metabolism in the Early Stages of Diet-Induced MASLD in Wistar Rats. International Journal of Molecular Sciences 2025; 26(3) doi: 10.3390/ijms26031288
|
| 4 |
Anna Kotlyarova, Stanislav Kotlyarov. Hepatocyte Models for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comparative Analysis of Non-HepG2 Cell Models. International Journal of Molecular Sciences 2026; 27(10) doi: 10.3390/ijms27104453
|
| 5 |
Shotaro Kamata, Isao Ishii. Difference Gel Electrophoresis. Methods in Molecular Biology 2023; 2596 doi: 10.1007/978-1-0716-2831-7_16
|
| 6 |
P. Brissot, C. Buffet. Rapport 23-02. Le foie stéatosique non alcoolique : un défi de santé publique. Bulletin de l'Académie Nationale de Médecine 2023; 207(5) doi: 10.1016/j.banm.2023.03.014
|
| 7 |
Baron J. Bechtold, Katherine D. Lynch, Victoria O. Oyanna, M. Ridge Call, Laura A. White, Tyler N. Graf, Nicholas H. Oberlies, John D. Clarke. Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B Mice. Drug Metabolism and Disposition 2024; 52(5) doi: 10.1124/dmd.123.001607
|
| 8 |
Kamlesh K. Bhopale, Mukund P. Srinivasan. Experimental Rodent Models of Metabolic Dysfunction-Associated Fatty Liver Disease: Present Status and Future Perspective. Livers 2026; 6(3) doi: 10.3390/livers6030045
|
| 9 |
Kinuko Uno, Kodai Shirasaka, Yamato Muro, Fuko Kuroki, Mei Nishida, Kumiko Yamaguchi, Kouhei Mandai, Keita Sekiguchi, Tomohiko Sasase, Masami Shinohara, Miki Sugimoto, Tatsuya Maekawa, Katsuhiro Miyajima, Takeshi Ohta. A high-fat/high-sucrose/high-cholesterol diet leads to early indications of metabolic dysfunction-associated steatohepatitis-like lesions in obese diabetic mice. The Journal of Toxicological Sciences 2026; 51(7) doi: 10.2131/jts.51.367
|